OHSU in the news

What Is COVID-19 Super Immunity?

Everyday Health March 10, 2022
Bill Messer, M.D., Ph.D., explains super immunity, and he begins with a refresher on what vaccines do: “Vaccines enable us to develop antibodies and immune cells that remember the virus if we’re exposed to it. The immune system takes lessons from the vaccine, applies those lessons to dealing with the infection, then acquires additional knowledge from the breakthrough infection. The combination gives our immune system a greater capacity to recognize the viruses that cause COVID-19, apart from what it learns from one or the other mode in isolation.”

CDC: Fentanyl deaths triple among teens over the last two years

KATU-TV March 08, 2022
Korthuis and 49 other physicians send a letter to Gov. Brown asking her to declare an emergency around the fentanyl overdose crisis. “Increasing awareness of the fentanyl problem and particularly targeting younger people who may not be aware that whatever they may be taking may not be as advertised, and may be something that's much more unforgiving and can cause death the first time."

Political Science

The Cut March 08, 2022
Erick Turner, M.D., is interviewed by The Cut, a podcast of New York magazine, about MDMA-assisted therapy.

'Are these symptoms allergies or are they COVID?' Early allergy season worries some

KGW-TV March 08, 2022
Shyam Joshi, M.D., tells KGW-TV that those with runny noses concerned about COVID-19 may be experiencing allergies: “We get that question quite frequently—‘Are these symptoms allergies or are they COVID?’ Sometimes it's hard to tell, but generally if we're seeing a lot more itchy watery eyes, sneezing, itchy nose, we're thinking most likely it's going to be allergies.”

Access to high-volume TAVR operators varies widely across US

Healio March 08, 2022
Research by Timothy Simpson, M.D., Pharm.D., finds more than a third of physicians who provide transcatheter aortic valve replacement, or TAVR, perform less than 10 procedures per year. Noting patients have better outcomes after undergoing TAVR with physicians who perform it more often, Simpson says: “Our study sheds light on an important policy conundrum: to balance equitable access to TAVR therapy for patients from all demographics while confirming we are providing high-quality outcomes to our patients."
See more stories